Youcare Pharmaceutical Group Co. Ltd. A (688658) — Working Capital to Net Assets Ratio
Youcare Pharmaceutical Group Co. Ltd. A (688658) has a Working Capital to Net Assets ratio of 37.9% as of March 2026. Working capital of CN¥1.24 Billion (current assets of CN¥2.52 Billion minus current liabilities of CN¥1.28 Billion) is measured against net assets of CN¥3.27 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See 688658 financial flexibility index to measure the company's free cash flow as a share of total liabilities.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Youcare Pharmaceutical Group Co. Ltd. A Working Capital to Net Assets (2017–2025)
This chart shows how Youcare Pharmaceutical Group Co. Ltd. A's Working Capital to Net Assets ratio has evolved across 9 annual periods from 2017 to 2025. As of March 2026, the ratio stands at 37.9%, reflecting working capital of CN¥1.24 Billion against net assets of CN¥3.27 Billion CNY. See Youcare Pharmaceutical Group Co. Ltd. A (688658) defensive interval to measure how many days the company can operate on defensive assets alone.
Annual Working Capital to Net Assets for Youcare Pharmaceutical Group Co. Ltd. A (2017–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Youcare Pharmaceutical Group Co. Ltd. A from 2017 to 2025, covering 9 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see Youcare Pharmaceutical Group Co. Ltd. A market capitalisation.
| Year | WC/NA Ratio | Working Capital (CNY) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 26.6% | CN¥911.87 Million | CN¥3.43 Billion | CN¥2.59 Billion | CN¥1.68 Billion | ▼ -19.5 pp |
| 2024 | 46.1% | CN¥1.65 Billion | CN¥3.58 Billion | CN¥3.16 Billion | CN¥1.51 Billion | ▲ +10.3 pp |
| 2023 | 35.8% | CN¥1.29 Billion | CN¥3.60 Billion | CN¥3.42 Billion | CN¥2.14 Billion | ▼ -14.3 pp |
| 2022 | 50.1% | CN¥2.00 Billion | CN¥4.00 Billion | CN¥3.90 Billion | CN¥1.90 Billion | ▼ -10.6 pp |
| 2021 | 60.7% | CN¥2.38 Billion | CN¥3.93 Billion | CN¥4.07 Billion | CN¥1.68 Billion | ▲ +1.8 pp |
| 2020 | 58.9% | CN¥2.11 Billion | CN¥3.59 Billion | CN¥3.89 Billion | CN¥1.78 Billion | ▲ +87.5 pp |
| 2019 | -28.6% | CN¥-321.57 Million | CN¥1.12 Billion | CN¥1.88 Billion | CN¥2.20 Billion | ▲ +38.5 pp |
| 2018 | -67.0% | CN¥-565.05 Million | CN¥842.76 Million | CN¥1.85 Billion | CN¥2.42 Billion | ▲ +14.6 pp |
| 2017 | -81.7% | CN¥-581.44 Million | CN¥711.86 Million | CN¥1.97 Billion | CN¥2.55 Billion | — |